South San Francisco, Calif., September 3, 2025 – TRex Bio, Inc. (“TRexBio”), a clinical-stage biotechnology company decoding human tissue immune biology to create revolutionary therapeutics, today announced that members of its management team will participate in two upcoming investor conferences in September: Morgan Stanley 23rd Annual Global Healthcare Conference taking place September 8-10, 2025, in […] The post TRexBio to Participate in Upcoming Investor Conferences in September appeared first on TrexBio .